Management of Oral Hypoglycemic Agents During Ramadan

Introduction to Medication Adjustments

Modern oral hypoglycemic agents like DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 agonists require minimal to no dose adjustment during Ramadan fasting, while sulfonylureas require significant dose reduction and timing changes to prevent hypoglycemia 1, 2, 3

Conduct a comprehensive pre-Ramadan assessment 6-8 weeks before fasting begins to evaluate glycemic control, renal function, hepatic status, and stratify patients by hypoglycemia risk 3, 4
Patients at very high risk should be strongly advised against fasting 4

The American Diabetes Association recommends continuing metformin with timing adjustment only, giving two-thirds of total daily dose immediately before Iftar and one-third before Suhoor 3, 4
DPP-4 inhibitors are the safest oral glucose-lowering medication class for Ramadan fasting, requiring no dose adjustment and minimizing hypoglycemia risk due to their glucose-dependent mechanism of action 1, 2, 3
SGLT2 inhibitors should be considered early in diabetes management, especially for patients with cardiovascular or renal disease, and require no dose adjustment 1, 2
GLP-1 agonists minimize hypoglycemia risk and require no dose adjustment, making them suitable for fasting periods 1, 2
For sulfonylureas, the American College of Clinical Endocrinologists recommends shifting the entire dose to before Iftar and considering reducing to 75% of the pre-Ramadan dose 4

The European Association for the Study of Diabetes recommends self-monitoring blood glucose intensively during the first 3-4 weeks, focusing on the first few hours after starting the fast, late afternoon before breaking fast, and post-Iftar to detect hyperglycemia 3, 6, 7
The International Diabetes Federation recommends breaking the fast immediately if blood glucose drops below 70 mg/dL, which is a non-negotiable safety threshold 3, 4
Target glycemic goals during Ramadan include time in range >70%, time below range <4%, and time in severe hypoglycemia <1% 6, 7, 8

The American Association of Clinical Endocrinologists recommends returning all medications to pre-Ramadan dosing and timing immediately after Ramadan ends 3
Assess overall glycemic control, complications, and the fasting experience to guide future Ramadan planning 3